Rachel Yu

Rachel Yu

Directeur Financier/CFO chez LAKESHORE BIOPHARMA CO., LTD
52 ans
Finance
Consumer Services
Health Technology

Profil

Rachel Yu is Chief Financial Officer & Director at LakeShore Biopharma Co., Ltd. since 2024.
Ms. Yu is Partner at Oceanpine Capital (US) since 2021.
Former roles include Research Associate at Deutsche Bank Securities, Inc. in 2010; Analyst at Rodman & Renshaw LLC (Old) from 2010 to 2011; Analyst at Maxim Group LLC in 2012; VP & Head-China Healthcare Research at Gerson Lehman Group (Asia) Ltd. from 2012 to 2014; Partner at China Renaissance Holdings Ltd. from 2014 to 2021.
Education includes undergraduate degree from Guangdong Pharmaceutical University, MBA from The University of Chicago Booth School of Business, and graduate degree from the University of Missouri School of Medicine.

Postes actifs de Rachel Yu

SociétésPosteDébut
LAKESHORE BIOPHARMA CO., LTD Directeur Financier/CFO 01/06/2024
Oceanpine Capital (US)
Private Equity Investor 01/05/2021

Anciens postes connus de Rachel Yu

SociétésPosteFin
CHINA RENAISSANCE HOLDINGS LIMITED Corporate Officer/Principal 01/01/2021
Gerson Lehman Group (Asia) Ltd.
Corporate Officer/Principal 01/01/2014
Analyst-Equity 01/09/2012
Analyst-Equity 20/05/2011
Analyst-Equity 31/01/2010
Voir l'expérience en détail de Rachel Yu

Formation de Rachel Yu

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

64

Relations au 1er degré

10

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées10

Finance

Finance

Finance

Consumer Services

Consumer Services

Finance

Consumer Services

Gerson Lehman Group (Asia) Ltd.

Oceanpine Capital (US)

Health Technology